Navigation Links
'Generalist bacteria' discovered in coastal waters may be more flexible than known before
Date:1/27/2008

been able to begin identifying the bacteria in oceans at all. Part of this is simply because ocean bacteria are notoriously hard to culture in the lab, and many cant be cultured yet at all. This makes studying them extremely difficult. New methods, however, are making such studies easier. One of them, which formed the basis for this research, is metagenomics, which bypasses the culturing step entirely by directly sequencing the mixture of bacterial genomes in seawater.

Understanding more about the genomes of bacteria has allowed researchers to ask much narrower questions than ever before, and the result has been a new ability to understand how marine bacteria live and interact in the ocean.

The research in the current study was done in an area off the coast of Sapelo Island, Ga., and while the findings about bacterial generalists may hold true for similar coastal ecosystems, researchers dont know if the same will be true in deep-ocean or other sea environments.

We can understand a great deal about the health of the oceans by understanding more about how the bacteria that live in our coastal waters function, said Moran.

The idea for bacterial generalists isnt new, but this is the first experimental evidence for marine coastal bacteria as generalists.


'/>"/>

Contact: Kim Osborne
kosborne@uga.edu
706-542-8083
University of Georgia
Source:Eurekalert

Page: 1 2

Related biology news :

1. Team IDs weakness in anthrax bacteria
2. Bacterial infections in premature babies more common than previously realized
3. Multiple species of bacteria may cause trachoma: Implications for treatment
4. New drug targets may fight tuberculosis and other bacterial infections in novel way
5. Jekyll and Hyde bacteria offer pest control clue
6. Bacteria that cause urinary tract infections invade bladder cells
7. Nanotube-producing bacteria show manufacturing promise
8. CU-Boulder technology used to identify unexpected bacteria in cystic fibrosis patients
9. Small RNA plays parallel roles in bacterial metabolism
10. Together we stand: bacteria organize to survive hostile zones
11. Chemical compound present in detergents produce bacteria alterations in agricultural soils
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/6/2009)...dy,s primal cells, retaining the youthful ability ...er many cycles of cell division. How do they do it...tified a gene, named scrawny, that appears to be a...their undifferentiated state. Understanding how st...oth for our knowledge of basic biology and also fo...
(Date:1/6/2009)...roup of scientists is linking nutrient pollution i...umber of harmful algal blooms reported in recent y...y taint seafood with toxins, cause human respirato...ills in coastal waters. , In the December editi...ent a compilation of 21 articles outlining the rol...
(Date:1/6/2009)...es back at least 8,000 years but it seems we still... for turning milk into cheese., Now an internatio...identified a new line of bacteria they believe add...eses. , The team used DNA fingerprinting techniqu...bes on the French cheese Reblochon. , One of Fran...
(Date:1/6/2009)...ional study fails to support the common belief tha...ty is a key factor in rising rates of obesity. , ...and other centers compared African American women ...a. On average, the Chicago women weighed 184 pound...esearchers had expected to find that the slimmer N...
Breaking Biology News(10 mins):'Scrawny' gene keeps stem cells healthy 2Wonderful cheese is all in the culture 2Physical activity may not be key to obesity epidemic 2Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 1663 1Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 1663 2Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 1663 3Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 1663 4Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 1663 5Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 1663 6Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 1663 7Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 1663 8Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 1663 9Mindray Medical International Announces Third Quarter 2007 Results 1660 1Mindray Medical International Announces Third Quarter 2007 Results 1660 2Mindray Medical International Announces Third Quarter 2007 Results 1660 3Mindray Medical International Announces Third Quarter 2007 Results 1660 4Mindray Medical International Announces Third Quarter 2007 Results 1660 5Mindray Medical International Announces Third Quarter 2007 Results 1660 6Mindray Medical International Announces Third Quarter 2007 Results 1660 7Mindray Medical International Announces Third Quarter 2007 Results 1660 8Mindray Medical International Announces Third Quarter 2007 Results 1660 9Mindray Medical International Announces Third Quarter 2007 Results 1660 10Mindray Medical International Announces Third Quarter 2007 Results 1660 11Mindray Medical International Announces Third Quarter 2007 Results 1660 12Mindray Medical International Announces Third Quarter 2007 Results 1660 13Mindray Medical International Announces Third Quarter 2007 Results 1660 14Mindray Medical International Announces Third Quarter 2007 Results 1660 15Mindray Medical International Announces Third Quarter 2007 Results 1660 16Mindray Medical International Announces Third Quarter 2007 Results 1660 17Mindray Medical International Announces Third Quarter 2007 Results 1660 18Mindray Medical International Announces Third Quarter 2007 Results 1660 19Mindray Medical International Announces Third Quarter 2007 Results 1660 20Two Point of Care Tests From Quest Diagnostics Receive FDA 510 28k 29 Clearance 729 1Two Point of Care Tests From Quest Diagnostics Receive FDA 510 28k 29 Clearance 729 2Two Point of Care Tests From Quest Diagnostics Receive FDA 510 28k 29 Clearance 729 3Two Point of Care Tests From Quest Diagnostics Receive FDA 510 28k 29 Clearance 729 4Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First Line Treatment of Metastatic Colorectal Cancer 726 1Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First Line Treatment of Metastatic Colorectal Cancer 726 2Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First Line Treatment of Metastatic Colorectal Cancer 726 3Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First Line Treatment of Metastatic Colorectal Cancer 726 4Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First Line Treatment of Metastatic Colorectal Cancer 726 5
...e National Human Genome Research Institute (NHGRI)...today announced several new sequencing targets inc... leucogenys), setting the stage for completing a q...man primate genome from each of the major position...vailable an essential resource for researchers unr...
...major Canadian-led global study has found all form...ewing or inhaling second hand smoke, increase the ...alim Yusuf and Koon Teo of the Michael G. DeGroote...ilton Health Sciences in Hamilton, is published in...tion with colleagues from 52 countries, they calcu...
...inforests and savannas contain 70% of the world,s ...t. A new £1.6m international project involving res...ute is looking at the impact of global warming on ...may be at the start of a vicious cycle, where glob...creasing the amount of carbon in the atmosphere, r...
...pioneering collaboration among U.S., European and ...ll seek to identify genetic differences in the way...um, led by scientists at Duke University, investig...f HIV will share access to patient groups, called ...sortium is provided by the Center for HIV/AIDS Vac...
Other Biology News:NHGRI announces latest sequencing targets 2NHGRI announces latest sequencing targets 3NHGRI announces latest sequencing targets 4NHGRI announces latest sequencing targets 5NHGRI announces latest sequencing targets 6Global study shows all tobacco bad for the heart 2Global study shows all tobacco bad for the heart 3The vicious cycle of rainforest destruction 2CHAVI announces international search for genes affecting HIV response 2CHAVI announces international search for genes affecting HIV response 3
(Date:1/7/2009)...SOUTH SAN FRANCISCO, Calif., Jan. 7 /PRNewswire-Fi...: PARD ), a biopharmaceutical company focused on...hat the Company will present,data from two ongoin...oming,American Society of Clinical Oncology (ASCO...present updated data from its Phase 2 trial,of pi...
(Date:1/7/2009)...PALO ALTO, Calif., Jan. 7 Intradig...ystemic RNA interference (RNAi) therapeutics, toda... tranche of its Series B,financing. Astellas Vent...,existing investor, Lilly Ventures, also participa...al Series B financing to $21.4 million. Intradigm...
(Date:1/7/2009)...BRUSSELS, January 7 , - Mos...le-East , Ansell Healthcare, a global leade...ar history of R&D, will be showcasing the most...i, from 26 to 29 January 2009 (Hall 6 Booth E10).,... comprehensive Gammex(R),range including the late...
(Date:1/6/2009)...SHANGHAI, China, Jan. 6 /PRNewswire-Asia/ -- WuXi ... pharmaceutical, biotechnology, and medical device...h operations in China and the,United States, toda... and,Chief Executive Officer, will present at the... Tuesday, January 13, 2009, at 4:30 pm Pacific,St...
Breaking Biology Technology:Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers 2Poniard Pharmaceuticals to Present Data from Phase 2 Clinical Trials of Picoplatin in Colorectal and Prostate Cancers 3Intradigm Closes Final Tranche of $21.4 Million Series B Financing 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 3Managing Risk Through Quality: Ansell Healthcare's Innovative Gammex(R) Glove Range on Display at Arab Health 2009 2WuXi PharmaTech to Present at 27th Annual J.P. Morgan Healthcare Conference 2
...te about very unprofessional, clueless or off-the-...ile theyre all true stories and authentic trends, ... only managers who behave outrageously. So you kno...heres a story about a technology job candidate tha...view a very senior candidate for a Chicago-based t...
...f Wisconsin-Madison Board of Regents has approved ... be built near UW Hospital and Clinics and the ...eted in spring 2008, awaits approval from the Stat... phase of the project will include laboratory faci...ters. The facility is designed to encourage a mult...
...nus, as viewed in this composite image, by the Kec...esy of Lawrence Sromovsky, UW-Madison Space Scienc...ical capabilities of the Keck Telescope , scienti...phere of Uranus, providing new insight into some o..., ,A pair of images unveiled on Wednesday at a mee...
...nologies has expanded its product pipeline and wi...the next few years, the company told investors and...n, makes molecular genetic diagnostics. , ,The com... primarily by its genetics, cystic fibrosis and he...A clearance for certain coagulation tests next yea...
Other Biology Technology:What to do when dining with a Jive Turkey technology job candidate 2What to do when dining with a Jive Turkey technology job candidate 3What to do when dining with a Jive Turkey technology job candidate 4UW space scientists use Keck telescope to study wild weather of Uranus 2UW space scientists use Keck telescope to study wild weather of Uranus 3
...sformation of the budding yeast, Saccharoyces sp..... simply by mixing a plasmid DNA and the kit reagen..., such as centrifugation or cell washing, are requ...-throughput transformation of a large number of ye...
...sformation of the budding yeast, Saccharoyces sp..... simply by mixing a plasmid DNA and the kit reagen..., such as centrifugation or cell washing, are requ...-throughput transformation of a large number of ye...
...b productivity and allows you to achieve a higher ...head beyond traditional paper-based weighing proce...tem. *Instruments supported: Control of MET... PG, SG, AT, MT, UMT, AB-S, PB-S, PB-L balances *...
XPLAC (S-17)
Biology Products: